CD39 inhibitor (POM-1) enhances radiosensitivity of esophageal squamous cell carcinoma (ESCC) cells by promoting apoptosis through the Bax/Bcl-2/Caspase 9/Caspase 3 pathway

Autor: Wang, Yuchen, Zhang, Ruijuan, Huang, Xinran, He, Xinyu, Geng, Shangyi, Pan, Shupei, Guo, Wei, Liu, Xiaoxiao, Dang, Yongze, Qu, Jingkun, Ma, Hongbing, Zhao, Xixi
Zdroj: In International Immunopharmacology 5 December 2024 142 Part B
Databáze: ScienceDirect
Externí odkaz: